Baloxavir clinical trials
Also written Xofluza and S-033188.
Its developmentBy Hoffmann-La Roche and Shionogi, step by step10 company-led studies, furthest phase 3: when each phase was reached, its deals, target and what is ahead.How each study uses baloxavir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the baloxavir studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 24 Oct 2018 · XOFLUZA · NDA 210854 (FDA, Drugs@FDA)
- European Union
- 7 Jan 2021 · Xofluza · EMEA/H/C/004974 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
20 studies that test it; most in 2019 (5)
| Year | Studies |
|---|---|
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 10 · Other 10
Hoffmann-La Roche (8) · Shionogi (2) · University of Oxford (2) · Bassett Healthcare (1) · Children's Hospital of Philadelphia (1) · University of Washington (1) · Capital Medical University (1) · UMC Utrecht (1)
Often tested with
Tested in the same studies.
Oseltamivir (3) · Hydroxychloroquine (2) · Interleukin 1 Receptor Antagonist Protein (2) · Tocilizumab (2) · Aspirin (2) · Baricitinib (2) · Nirmatrelvir and ritonavir drug combination (2) · Molnupiravir (2)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 5, 4 in phase 3
Studies that test baloxavir, phase 3 first.
- Mar 2027Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp)Phase 3 · Unity Health Toronto
- Apr 2027Efficacy of Baloxavir Against Influenza in Hospitalized Patients: The INFLUENT Study (INpatients inFLUENza Treatment)Phase 3 · Dre Pauline Vetter
- Apr 2027A Study to Confirm Efficacy of a Single Dose of Baloxavir Marboxil in the Post-exposure Prophylaxis (PEP) of Influenza Virus Infection in Chinese ParticipantsPhase 3 · Hoffmann-La Roche
- May 2027A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household ContactsPhase 3 · Hoffmann-La Roche
- Jan 2027A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic InfluenzaPhase 2 · University of Oxford
Studies
Open first, then newest update. How each study uses baloxavir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 20
- A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household ContactsRecruitingPhase 3Hoffmann-La RocheNCT06094010Written as Baloxavir MarboxilHow we know
- A Study to Confirm Efficacy of a Single Dose of Baloxavir Marboxil in the Post-exposure Prophylaxis (PEP) of Influenza Virus Infection in Chinese ParticipantsRecruitingPhase 3Hoffmann-La RocheNCT07827599Written as Baloxavir marboxilHow we know
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired PneumoniaRecruitingPhase 3UMC UtrechtNCT02735707Written as Baloxavir MarboxilHow we know
- Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp)RecruitingPhase 3Unity Health TorontoNCT07314905Written as BaloxavirHow we know
- Efficacy of Baloxavir Against Influenza in Hospitalized Patients: The INFLUENT Study (INpatients inFLUENza Treatment)RecruitingPhase 3Dre Pauline VetterNCT06653569Written as Baloxavir MarboxilHow we know
- Randomised Evaluation of COVID-19 TherapyRecruitingPhase 3University of OxfordNCT04381936Written as Baloxavir MarboxilHow we know
- A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic InfluenzaRecruitingPhase 2University of OxfordNCT05648448Written as BaloxavirHow we know
- Oseltamivir and Baloxavir Marboxil for Prophylaxis Against Influenza Under a Hospital-based SettingNot yet recruitingNot applicableCapital Medical UniversityNCT06762587Written as Baloxavir MarboxilHow we know
- COmbination Therapy With Baloxavir and Oseltamivir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1)CompletedPhase 2/3Bassett HealthcareNCT04327791Written as BaloxavirHow we know
- Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Chinese Pediatric Participants 1 to <12 Years of Age With Influenza SymptomsCompletedPhase 3Hoffmann-La RocheNCT06774859Written as Baloxavir MarboxilHow we know
- Xofluza-Wearables Feasibility-StudyCompletedPhase 4Children's Hospital of PhiladelphiaNCT06161454Written as Baloxavir MarboxilHow we know
- Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in HouseholdsCompletedPhase 3Hoffmann-La RocheNCT03969212Written as Baloxavir MarboxilHow we know
- Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants From Birth to < 1 Year With Influenza-Like SymptomsCompletedPhase 3Hoffmann-La RocheNCT03653364Written as Baloxavir MarboxilHow we know
- Baloxavir Versus Oseltamivir for Nursing Home Influenza OutbreaksStatus unknownPhase 4Insight Therapeutics, LLCNCT05012189Written as BaloxavirHow we know
- Pilot of Cohort of Households for Influenza Monitoring and Evaluation in SeattleCompletedPhase 4University of WashingtonNCT04141930Written as Baloxavir MarboxilHow we know
- Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe InfluenzaCompletedPhase 3Hoffmann-La RocheNCT03684044Written as Baloxavir MarboxilHow we know
- Study to Assess the Pharmacokinetics, Safety and Tolerability of Baloxavir Marboxil in Healthy Chinese ParticipantsCompletedNot applicableHoffmann-La RocheNCT03959332Written as Baloxavir MarboxilHow we know
- Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants With Influenza-Like SymptomsCompletedPhase 3Hoffmann-La RocheNCT03629184Written as Baloxavir MarboxilHow we know
- Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza ComplicationsCompletedPhase 3ShionogiNCT02949011Written as Baloxavir MarboxilHow we know
- A Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With InfluenzaCompletedPhase 3ShionogiNCT02954354Written as Baloxavir MarboxilHow we know
Given beside what is tested · 1 — baloxavir is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with baloxavir
- A Prospective, Multicenter, Randomized Controlled Clinical Study on the Efficacy and Safety of Xuanfei Baidu Granule in the Treatment of Influenza ARecruitingNot applicableCapital Medical UniversityNCT06205641Written as Baloxavir Marboxil TabletHow we know
- Safety and Efficacy of ADC189 in Children 2-11 Years Old With InfluenzaCompletedPhase 3Jiaxing AnDiCon Biotech Co.,LtdNCT06507813Written as Baloxavir Marboxil tabletsHow we know
- Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With InfluenzaTerminatedPhase 2/3Weill Medical College of Cornell UniversityNCT05170009Written as Baloxavir MarboxilHow we know
What changed recently
From the registry's own updates since Oct 20, 2026.
Started recruiting1
Codes
What other systems call baloxavir · ClinicalTrials.gg INT000987
- MeSH (NLM) C000628402baloxavirConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 4G86Y4JT3FBALOXAVIRConfirmed FDA, NLM, Wikidata
- RxNorm 2197842One source FDA
- Wikidata Q57742876baloxavirConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C166756BaloxavirOne source FDA
- DrugBank DB15675One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000628402 | baloxavir | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 4G86Y4JT3F | BALOXAVIR | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2197842 | — | One source FDA |
| Wikidata | Q57742876 | baloxavir | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C166756 | Baloxavir | One source FDA |
| DrugBank | DB15675 | — | One source Wikidata |
Also registered as baloxavir marboxil (UNII 505CXM6OHG · RxNorm 2099995).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.